Document is current
Any future updates will be listed below
-
Authors
Gala, Khushboo
Ghusn, Wissam
Fansa, Sima
Abu Dayyeh, Barham K.
Ghanem, Omar M.
Kellogg, Todd
Acosta, Andres https://orcid.org/0000-0003-2286-489X
- License Information
-
More Information
Article History
Received: 27 September 2022
Revised: 9 January 2023
Accepted: 17 January 2023
First Online: 28 January 2023
Declarations
:
: All the procedures performed in the studies involving human participants were in accordance with the Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all the individual participants included in the study.
: Khushboo Gala, Wissam Ghusn, Sima Fansa, Omar Ghanem, and Todd Kellogg have no conflict of interests.Barham K. Abu Dayyeh has received consulting fee from Endogenex, Endo-TAGSS, Metamodix, and BFKW; consulting fee and grant/research support from USGI, Cairn Diagnostics, Aspire Bariatrics, Boston Scientific; speaker honorarium from Olympus, Johnson and Johnson; speaker honorarium and grant/research support from Medtronic, EndoGastric Solutions; and research support/grant from Apollo Endosurgery and and Spatz Medical.Andres Acosta is a stockholder in Gila Therapeutics and Phenomix Sciences; he served as a consultant for Rhythm Pharmaceuticals and General Mills.
